Papers matching “pathological complete response” in Breast Cancer Treatment Studies 46
Not finding it? Sign in to also search OpenAlex live.
-
A review of the association between baseline [18F] fluorodeoxyglucose uptake and axillary pathological complete response in node-positive breast cancer patients: focus on clinical subtypes2025 Nuclear Medicine Communications article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Melissa Lenaerts, Florien J G van Amstel, Felix Manuel Mottaghy, Sandra M. E. Geurts, Vivianne C. G. Tjan‐Heijnen, Marjolein L. Smidt, +1 more
5citations -
Tumor‐stroma ratio is associated with Miller‐Payne score and pathological response to neoadjuvant chemotherapy in HER2 ‐negative early breast cancer2021 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Sophie C. Hagenaars, Stefanie de Groot, Danielle B. Cohen, Tim J. A. Dekker, Ayoub Charehbili, Elma Meershoek‐Klein Kranenbarg, +6 more
43citations -
Tumor-stroma ratio is associated with Miller-Payne and pathological response to neoadjuvant chemotherapy in HER2-negative early breast cancer2020 European Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Sophie C. Hagenaars, S de Groot, Danielle B. Cohen, Ayoub Charehbili, Tim J. A. Dekker, Elma Meershoek‐Klein Kranenbarg, +6 more
3citations -
On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer2024 Breast Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Bruno Valentin Sinn, Katharina Sychra, M. Untch, Thomas Karn, Marion van Mackelenbergh, Jens Huober, +13 more
8citations -
Abstract P1-10-01: Caveolin gene expression predicts for response and clinical outcomes of patients treated with preoperative paclitaxel-based chemotherapy regimens in early stage breast cancer2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Terence Marques Williams, Andreas Schneeweiß, Christian Jackisch, Changxian Shen, Karsten Ernst Weber, Peter Andreas Fasching, +16 more
0citations -
BluePrint molecular subtypes predict response to neoadjuvant pertuzumab in HER2-positive breast cancer2023 Breast Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Marte C. Liefaard, Anna van der Voort, Mette S. van Ramshorst, Joyce Sanders, Shiva Vonk, Hugo M. Horlings, +10 more
6citations -
Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial2023 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Peter Andreas Fasching, Christopher W. Szeto, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Patricia Spilman, +18 more
8citations -
Data from Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial
Peter Andreas Fasching, Christopher W. Szeto, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Patricia Spilman, +18 more
1citations -
Data from Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial
Peter Andreas Fasching, Christopher W. Szeto, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Patricia Spilman, +18 more
0citations -
Data from Inferred Immune-Cell Activity Is an Independent Predictor of HER2-Negative Breast Cancer Prognosis and Response to Paclitaxel-Based Therapy in the GeparSepto Trial
Peter Andreas Fasching, Christopher W. Szeto, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Patricia Spilman, +18 more
0citations -
Immune-related Gene Expression Predicts Response to Neoadjuvant Chemotherapy but not Additional Benefit from PD-L1 Inhibition in Women with Early Triple-negative Breast Cancer2021 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Bruno Valentin Sinn, Sibylle Loibl, Claus Alexander Hanusch, Dirk-Michael Zahm, Hans‐Peter Sinn, Michael Untch, +16 more
46citations -
An Analysis of PIK3CA Hotspot Mutations and Response to Neoadjuvant Therapy in Patients with Breast Cancer from Four Prospective Clinical Trials2024 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Paul Jank, Thomas Karn, Marion van Mackelenbergh, Judith Lindner, Denise Treue, Jens Huober, +18 more
13citations -
Value of breast and axillary tumour-infiltrating lymphocytes for response to neoadjuvant chemo-(immuno)therapy in clinically node-positive breast cancer2026 Clinical Breast Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Melissa Lenaerts, Loes F. S. Kooreman, Florien J G van Amstel, P. J. van Diest, Sander M. J. van Kuijk, Ernest J. T. Luiten, +28 more
0citations -
Abstract PD5-08: Tumor immune-cell activity assessed by RNAseq is an independent predictor of therapy response and prognosis after neoadjuvant chemotherapy in HER2 negative breast cancer patients - An analysis of the GeparSepto trial2020 Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies cited by 1 patent
Peter Andreas Fasching, Carsten Denkert, Stephen Charles Benz, Karsten Ernst Weber, Christopher W. Szeto, Jan Budczies, +17 more
1citations -
Pathologic response of ductal carcinoma in situ to neoadjuvant systemic treatment in HER2-positive breast cancer2021 Breast Cancer Research and Treatment article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Emma Josephine Groen, Marieke E. M. van der Noordaa, Michael Schaapveld, Gabe S. Sonke, Ritse M. Mann, Mette S. van Ramshorst, +4 more
17citations -
Abstract PS4-08-07: Predicting response and survival after neoadjuvant systemic treatment with on-treatment biopsies2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
C. Denkert, A. Schneeweiss, V Schaser, Michael Untch, M. Van Mackelenbergh, J.-U. Blohmer, +17 more
0citations -
A Small Hypoxia Signature Predicted pCR Response to Bevacizumab in the Neoadjuvant GeparQuinto Breast Cancer Trial2020 Clinical Cancer Research article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Thomas Karn, Tobias Meißner, Karsten Ernst Weber, Christine Solbach, Carsten Denkert, Knut Engels, +19 more
16citations -
Prediction of axillary response in 5,262 patients with node-positive breast cancer treated with neoadjuvant chemotherapy: Results from the prospective multicenter AXSANA/EUBREAST-03/AGO-B-053 study.2026 Journal of Clinical Oncology conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Maggie Banys‐Paluchowski, Thorsten Kühn, Steffi Hartmann, Jana de Boniface, Nina Caroline Ditsch, Oreste Gentilini, +15 more
0citations -
On-treatment biopsies to predict response to neoadjuvant chemotherapy for breast cancer2024 Research Square preprint Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Bruno Valentin Sinn, Katharina Sychra, Michael Untch, Thomas Karn, Marion van Mackelenbergh, Jens Huober, +13 more
0citations -
The Predictive Value of the Tumor‐Stroma Ratio for Neoadjuvant Endocrine Therapy in Hormone Receptor‐Positive Breast Cancer2026 International Journal of Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Layla Andour, Sophie C. Hagenaars, Anne Florine de Groot, Elly MM Krol-Warmerdam, Judith R. Kroep, Hans Marten Hazelbag, +3 more
1citations -
EVI1 expression in early-stage breast cancer patients treated with neoadjuvant chemotherapy2022 BMC Cancer article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Jonas Leichsenring, Valentina A. Vladimirova, Christine Solbach, Thomas Karn, Beyhan Ataseven, Bruno Valentin Sinn, +14 more
1citations -
Tumor-Infiltrating Lymphocytes and Preoperative Partial Breast Irradiation in Early-Stage Breast Cancer: Insights From the Prospective PAPBI Cohort2025 International Journal of Radiation Oncology*Biology*Physics article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Jetske L B Gunster, Emma Josephine Groen, Roberto Salgado, Corrie A.M. Marijnen, Astrid N. Scholten
3citations -
MGMT promoter methylation in triple negative breast cancer of the GeparSixto trial2020 PLoS ONE article Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies Open access
Paul Jank, Claire Gehlhaar, Bianca Lederer, Caterina Fontanella, Andreas Schneeweiss, Thomas Karn, +15 more
11citations -
Abstract RF2-01: Prognostic Markers in Residual Tumors after neoadjuvant chemotherapy (NACT) for Early Triple-negative Breast Cancer (TNBC) - a Pooled Analysis from nine Neoadjuvant GBG/AGO-B Trials2026 Clinical Cancer Research conference-abstract Biochemistry, Genetics and Molecular Biology Breast Cancer Treatment Studies
Johannes Holtschmidt, A. Schneeweiss, Nadine Frickel, Natalie Filmann, Michael Untch, A. D. Hartkopf, +20 more
3citations